Chemotherapy-Induced Myelosuppression in SCLC
ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelosuppression Events in Pts With ES-SCLC: Post-Hoc Analyses of Data From Randomized Clinical Trials
By
ASCO 2022 Conference Coverage
FEATURING
Jerome Goldschmidt
By
ASCO 2022 Conference Coverage
FEATURING
Jerome Goldschmidt
Comments 0
Login to view comments.
Click here to Login